These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 6128271)
1. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy. Kapetanakis E; Dmowski WP; Auletta F; Scommegna A Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271 [TBL] [Abstract][Full Text] [Related]
2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
3. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes. Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814 [TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947 [TBL] [Abstract][Full Text] [Related]
5. Laboratory criteria for menopause in women using oral contraceptives. Creinin MD Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618 [TBL] [Abstract][Full Text] [Related]
6. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy. Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279 [TBL] [Abstract][Full Text] [Related]
7. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action. Richardson DW; Gordon K; Billiar RB; Little AB Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275 [TBL] [Abstract][Full Text] [Related]
8. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women. Wide L; Naessén T; Eriksson K; Rune C Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177 [TBL] [Abstract][Full Text] [Related]
9. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause. Chakravarti S; Collins WP; Thom MH; Studd JW Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937 [TBL] [Abstract][Full Text] [Related]
10. Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the alpha estrogen receptor null mice. Bartolone L; Smedile G; Arcoraci V; Trimarchi F; Benvenga S J Endocrinol Invest; 2000; 23(7):467-72. PubMed ID: 11005272 [TBL] [Abstract][Full Text] [Related]
12. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [TBL] [Abstract][Full Text] [Related]
13. 17 beta-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause. Wide L; Naessén T Clin Endocrinol (Oxf); 1994 Jun; 40(6):783-9. PubMed ID: 8033370 [TBL] [Abstract][Full Text] [Related]
14. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
15. Absorption of percutaneous oestradiol in postmenopausal women. Sitruk-Ware R; de Lignieres B; Basdevant A; Mauvais-Jarvis P Maturitas; 1980 Oct; 2(3):207-11. PubMed ID: 6777634 [TBL] [Abstract][Full Text] [Related]
16. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women. Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393 [TBL] [Abstract][Full Text] [Related]
17. Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta. Fiet J; Hermano M; Witte J; Villette JM; Haimart M; Gourmel B; Tabuteau F; Rouffy J; Dreux C Acta Endocrinol (Copenh); 1982 Sep; 101(1):93-7. PubMed ID: 6812348 [TBL] [Abstract][Full Text] [Related]
18. Effect of premenopausal castration and incremental dosages of conjugated equine estrogens on plasma follicle-stimulating hormone, luteinizing hormone, and estradiol. Utian WH; Katz M; Davey DA; Carr PJ Am J Obstet Gynecol; 1978 Oct; 132(3):297-302. PubMed ID: 212949 [TBL] [Abstract][Full Text] [Related]
19. Endometrium and plasma hormone profile in the peri-menopause and post-menopause. Trévoux R; De Brux J; Castanier M; Nahoul K; Soule JP; Scholler R Maturitas; 1986 Dec; 8(4):309-26. PubMed ID: 3106758 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]